These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21592347)

  • 1. Culturally-tailored smoking cessation for American Indians: study protocol for a randomized controlled trial.
    Choi WS; Faseru B; Beebe LA; Greiner AK; Yeh HW; Shireman TI; Talawyma M; Cully L; Kaur B; Daley CM
    Trials; 2011 May; 12():126. PubMed ID: 21592347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.
    Cox LS; Faseru B; Mayo MS; Krebill R; Snow TS; Bronars CA; Nollen NL; Choi WS; Okuyemi KS; Salzman GA; Benowitz NL; Tyndale RF; Ahluwalia JS
    Trials; 2011 Jan; 12():22. PubMed ID: 21266057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All Nations Breath of Life: A Randomized Trial of Smoking Cessation for American Indians.
    Choi WS; Beebe LA; Nazir N; Kaur B; Hopkins M; Talawyma M; Shireman TI; Yeh HW; Greiner KA; Daley CM
    Am J Prev Med; 2016 Nov; 51(5):743-751. PubMed ID: 27436332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD; Dugan SE
    Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of varenicline and cognitive bias modification on neural response to smoking-related cues: study protocol for a randomized controlled study.
    Attwood AS; Williams T; Adams S; McClernon FJ; Munafò MR
    Trials; 2014 Oct; 15():391. PubMed ID: 25294104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a culturally tailored smoking cessation for Chinese American smokers.
    Wu D; Ma GX; Zhou K; Zhou D; Liu A; Poon AN
    Nicotine Tob Res; 2009 Dec; 11(12):1448-57. PubMed ID: 19915080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing the default for tobacco-cessation treatment in an inpatient setting: study protocol of a randomized controlled trial.
    Faseru B; Ellerbeck EF; Catley D; Gajewski BJ; Scheuermann TS; Shireman TI; Mussulman LM; Nazir N; Bush T; Richter KP
    Trials; 2017 Aug; 18(1):379. PubMed ID: 28806908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
    JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial.
    Schnoll RA; Cappella J; Lerman C; Pinto A; Patterson F; Wileyto EP; Bigman C; Leone F
    Health Commun; 2011 Dec; 26(8):735-42. PubMed ID: 21667366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of Implementing the All Nations Breath of Life Culturally Tailored Smoking Cessation Program for American Indians in Multi-Tribal Urban Communities.
    Daley CM; Daley SM; Pacheco CM; Smith TE; Talawyma M; McCloskey C; Choi WS; Nazir N; Filippi MK; McKinney D; Gunville J; Greiner KA
    Nicotine Tob Res; 2018 Apr; 20(5):552-560. PubMed ID: 28177511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco smoking cessation management: integrating varenicline in current practice.
    Galanti LM
    Vasc Health Risk Manag; 2008; 4(4):837-45. PubMed ID: 19066000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a tailored approach for tobacco dependence treatment for American Indians.
    D'Silva J; Schillo BA; Sandman NR; Leonard TL; Boyle RG
    Am J Health Promot; 2011; 25(5 Suppl):S66-9. PubMed ID: 21510789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S
    J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
    Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
    Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical trial to examine disparities in quitting between African-American and White adult smokers: Design, accrual, and baseline characteristics.
    Nollen NL; Cox LS; Yu Q; Ellerbeck EF; Scheuermann TS; Benowitz NL; Tyndale RF; Mayo MS; Ahluwalia JS
    Contemp Clin Trials; 2016 Mar; 47():12-21. PubMed ID: 26667382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.